Lateral Flow Assay:

From Concept to Manufacture

A Practical Conference and Workshop exploring the Pathway from Concept to Production

10th and 11th October 2012 

Location: GE Healthcare Europe 

GmbHOskar-Schlemmer-Str.11  -  80807 München, Germany

Registration: 10th Oct, from 0900 hrs

Fee: €600 Course includes:

•  20 presentations with 4 practical sessions
• Course Workbook and Practical Materials for Production of Working Test
• Conference dinner on 10th October
• Lunches and refreshments

For more information, please contact: Alison Knoth – aknoth@dcndx.com or +1-858-336-7599

NEXT GENERATION Dx SUMMIT

Washington DC August 19-23, 2012

Corporate Sponsor Presentation:

Differentiating Your Lateral Flow Assay; High Sensitivity, Fluorescent Reader Based Assays with Enhanced Functionality – Dr. Brendan O’Farrell, President-DCN: will present this short course where attendees will learn about the key features of quantitative, sensitive, fluorescent lateral flow assays and be introduced to a novel method for the generations of highly functional signals in lateral flow; including parallel lines, arrays, letters, numbers or symbols; yielding intuitive, easily interpreted signals, simplified multiplexing and improved quantification.

Time and Date: Tuesday, August 21st, 2012 at 12:30pm

Morning Short Course:

Differentiating Lateral Flow Products from the Competition Based on Performance and Design – Dr. Brendan O’Farrell, President DCN & John Zeis, President Symbient Product Development: The purpose of this workshop is to outline the principles of advanced performance in lateral flow technology through the discussion of the key elements of design, development, manufacturing and supporting technology that allow for the use of this assay format in today’s highly demanding applications.

Time and Date: Monday, August 20th, 2012 9am-12pm

NEXT GENERATION Dx SUMMIT

Washington DC August 19-23, 2012

Corporate Sponsor Presentation:

Differentiating Your Lateral Flow Assay; High Sensitivity, Fluorescent Reader Based Assays with Enhanced Functionality – Dr. Brendan O’Farrell, President-DCN: will present this short course where attendees will learn about the key features of quantitative, sensitive, fluorescent lateral flow assays and be introduced to a novel method for the generations of highly functional signals in lateral flow; including parallel lines, arrays, letters, numbers or symbols; yielding intuitive, easily interpreted signals, simplified multiplexing and improved quantification.

Time and Date: Tuesday, August 21st, 2012 at 12:30pm

Morning Short Course:

Differentiating Lateral Flow Products from the Competition Based on Performance and Design – Dr. Brendan O’Farrell, President DCN & John Zeis, President Symbient Product Development: The purpose of this workshop is to outline the principles of advanced performance in lateral flow technology through the discussion of the key elements of design, development, manufacturing and supporting technology that allow for the use of this assay format in today’s highly demanding applications.

Time and Date: Monday, August 20th, 2012  9am-12pm

2012 AACC Clinical Lab Expo – Los Angeles, CA

Booth and Meetings

DCN will be exhibiting at the AACC Clinical Lab Expo 2012 in Los Angeles, CA, July 16-19th 2012. Please visit us at booth #538. If you would like to set up a meeting time, please contact Alison Knoth at aknoth@dcndx.com or at 858-336-7599.

Industry Workshop

DCN will be presenting an Industry Workshop where DCN and BioDot will introduce attendees to the principles of development and manufacturing of quantitative, multiplexed, highly sensitive lateral flow systems. A novel manufacturing process for the generation of non-traditional signal features in lateral flow will also be presented. These features, including numbers, letters, symbols and lines in the direction of flow, will allow for the development of results that are intuitive, easily interpreted and facilitate improved multiplexing and quantification.

Workshop Title: Stepping Over the Line: A Novel Approach to Developing Alpha-Numeric Results in Lateral Flow Products to Allow for Ease of Use, Quantification and Multiplexing

Location: Westin Bonaventure Hotel-Los Angeles, Avalon Room

Time and Date: July 17th, 2012 at 7am. Breakfast will be provided.

BioDot workshop: “From R&D to Quantitative IVDs”
Date: April 24-26
Location: Irvine Hyatt Regency, Irvine, CA.
Click for details

DCN is a key sponsor of this event, and will be presenting a seminar on Differentiating Your Rapid Assay from the Competition through performance and added functionality.

SPIE Conference on Defense Security and Sensing
Date: April 23-27
Location: Baltimore Convention Center, Baltimore, Maryland.
Click for details

Dr Brendan O’Farrell will be chairing a session and presenting a talk on the Development of Next Generation Rapid Diagnostic Assays. Dr Hans Boehringer will be presenting the results to date of the Development of a Rapid Assay for Determination of Hydrogen Cyanide Poisoning, a program which DCN is currently performing under the auspices of an SBIR grant.

CHI conference on Future Diagnostics
Date: April 16-17
Location: UC Irvine Student Center, Irvine CA
Click for details

DCN will be presenting a poster on the Generation of High Sensitivity, Quantitative, Multiplexed Lateral Flow Assay Systems.

Oak Ridge Conference
Date: April 19-20
Location: The Fairmont Hotel, San Jose, CA
Click for details

DCN will be attending and available for meetings. Please contact info@dcndx.com to arrange a meeting.

May 2012
BioDot Workshop: Lateral Flow Assays from Concept to Manufacture
Date: May 14-16
Location: Food and Environmental Research Agency, York, UK
Click for details

DCN is a key sponsor of this event, and will be presenting a seminar on Differentiating Your Rapid Assay from the Competition through performance and added functionality.

To Arrange Meetings: Please contact bofarrell@dcndx.com to arrange an appointment or request more information on DCN’s capabilities in the development of visual or fluorescent lateral flow immunoassays, any other aspect of the the SymBiosys program, or how we can assist you in designing, developing and manufacturing complete assay systems.

The World Health Organization has identified a group of diseases that are the world’s most pressing health problems. This represents an opportunity for test manufacturers, particularly in POC testing. Because of their ability to deliver fast results at the point of care, rapid testing is a focus area of healthcare providers and payors in infectious disease prevention.

This report examines this POC segment with a focus on new threats for which there are markets in the developing world and in developed countries.

Tests can only be marketed if they can be manufactured and if they can function in the healthcare environment. Thus, this report also discusses the technical choices, possibilities and limitations to today’s POC tests especially when they are used in the developing world. Reagent issues, testing on strips, instrumented and non-instrumented tests are coved in this report. These factors will impact what tests will reach the market and how they will function.

See more details, and purchase the report online from Kalorama’s website, here: http://www.kaloramainformation.com/Point-Care-Diagnostics-6429399/

DCN will be exhibiting and speaking on our expanding capabilities in the optimization and manufacturing of conjugates to fluorescent, visual and paramagnetic latex particles for use in diagnostic assays and prep scale separations. To set up an appointment to discuss your application, please contact Dr Roy Chung at rchung@dcndx.com or 760-804-3886.

For more details, or to register for the course, please click here